132 related articles for article (PubMed ID: 26685211)
21. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
Wanat KA; Anadkat MJ; Klekotka PA
J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
[TBL] [Abstract][Full Text] [Related]
22. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4⁺ T cells.
Yang C; Mosam A; Mankahla A; Dlova N; Saavedra A
J Am Acad Dermatol; 2014 Jun; 70(6):1096-102. PubMed ID: 24629995
[TBL] [Abstract][Full Text] [Related]
23. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
Mistry RD; Schwab SH; Treat JR
Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
25. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
Gowring LE; Johnson R; Hivnor CM; Henning JS
Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
[No Abstract] [Full Text] [Related]
27. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
[TBL] [Abstract][Full Text] [Related]
30. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity.
Jick H; Derby LE
Pharmacotherapy; 1995; 15(4):428-32. PubMed ID: 7479194
[TBL] [Abstract][Full Text] [Related]
31. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
[TBL] [Abstract][Full Text] [Related]
32. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
34. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
[TBL] [Abstract][Full Text] [Related]
35. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
[TBL] [Abstract][Full Text] [Related]
36. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
[TBL] [Abstract][Full Text] [Related]
37. Trimethoprim/sulfamethoxazole and metabolic acidosis in HIV-infected patients.
Porras MC; Lecumberri JN; Castrillón JL
Ann Pharmacother; 1998 Feb; 32(2):185-9. PubMed ID: 9496402
[TBL] [Abstract][Full Text] [Related]
38. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
39. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
40. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997.
Holtzer CD; Jacobson MA; Hadley WK; Huang L; Stanley HD; Montanti R; Wong MK; Stansell JD
AIDS; 1998 Oct; 12(14):1931-3. PubMed ID: 9792398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
